Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma

Alderuccio, JP; Desai, A; Yepes, MM; Chapman, JR; Vega, F; Lossos, IS

Lossos, IS (reprint author), Univ Miami, Miller Sch Med, Dept Med, Div Hematol, 1475 NW 12th Ave D8-4, Miami, FL 33136 USA.

CLINICAL CASE REPORTS, 2018; 6 (4): 634

Abstract

Key Clinical Message We report a woman who developed BIA-ALCL 9years after saline implant placement. The lymphoma manifested as a mass lesion associat......

Full Text Link